Watchlist Price Alert

Silexion Therapeutics LTD (SLXN)

NASDAQ: SLXN · Real-Time Price · USD

0.98

0.00 (0.30%)

At close: May 07, 2025, 3:58 PM

Silexion Therapeutics LTD Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q1 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Mar 31, 2023
Net Income	-1.75M	-11.86M	-1.49M	-1.42M	-1.68M	-809K	-774
Depreciation & Amortization	-12K	22K	7K	8K	6K	10K	15.00
Stock-Based Compensation	n/a	5.8M	32K	32.00	34K	32K	32.00
Other Working Capital	-1.08M	-947K	263K	-430K	422K	-155.16K	n/a
Other Non-Cash Items	-220K	3.82M	83K	167.97K	-47K	82.16K	-184
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-947K	-430K	302K	-505K	430K	-156	n/a
Operating Cash Flow	-2.93M	-2.65M	-1.06M	-1.75M	-1.26M	-685K	-911
Capital Expenditures	n/a	-16K	n/a	-6K	-4K	-6K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	78K	507.00
Investing Cash Flow	n/a	-16K	n/a	-6K	-4K	72K	507.00
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-250K	2.3M	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	2.18M	2.92M	n/a	n/a	n/a	n/a	n/a
Net Cash Flow	-753K	276K	-1.08M	-1.81M	-1.17M	-679K	7.92K
Free Cash Flow	-2.93M	-2.67M	-1.06M	-1.76M	-1.26M	-691K	-911